JP2013511566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511566A5 JP2013511566A5 JP2012540414A JP2012540414A JP2013511566A5 JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5 JP 2012540414 A JP2012540414 A JP 2012540414A JP 2012540414 A JP2012540414 A JP 2012540414A JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- factor
- pegylated protein
- buffer
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 108091006006 PEGylated Proteins Proteins 0.000 claims 6
- 230000002378 acidificating effect Effects 0.000 claims 4
- 239000012535 impurity Substances 0.000 claims 4
- 102100022641 Coagulation factor IX Human genes 0.000 claims 3
- 108010076282 Factor IX Proteins 0.000 claims 3
- 239000000872 buffer Substances 0.000 claims 3
- 229960004222 factor ix Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 102100023804 Coagulation factor VII Human genes 0.000 claims 2
- 108010023321 Factor VII Proteins 0.000 claims 2
- 108010014173 Factor X Proteins 0.000 claims 2
- 108010094028 Prothrombin Proteins 0.000 claims 2
- 238000005349 anion exchange Methods 0.000 claims 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims 2
- 238000011067 equilibration Methods 0.000 claims 2
- 239000006167 equilibration buffer Substances 0.000 claims 2
- 229940012413 factor vii Drugs 0.000 claims 2
- 208000031220 Hemophilia Diseases 0.000 claims 1
- 208000009292 Hemophilia A Diseases 0.000 claims 1
- 102000017975 Protein C Human genes 0.000 claims 1
- 229940096437 Protein S Drugs 0.000 claims 1
- 102000029301 Protein S Human genes 0.000 claims 1
- 108010066124 Protein S Proteins 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 claims 1
- 238000005571 anion exchange chromatography Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 239000012149 elution buffer Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229960000856 protein c Drugs 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09176881 | 2009-11-24 | ||
| EP09176881.2 | 2009-11-24 | ||
| US26448609P | 2009-11-25 | 2009-11-25 | |
| US61/264,486 | 2009-11-25 | ||
| PCT/EP2010/068112 WO2011064247A1 (en) | 2009-11-24 | 2010-11-24 | Method of purifying pegylated proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013511566A JP2013511566A (ja) | 2013-04-04 |
| JP2013511566A5 true JP2013511566A5 (enExample) | 2014-01-16 |
| JP5827955B2 JP5827955B2 (ja) | 2015-12-02 |
Family
ID=41401820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540414A Active JP5827955B2 (ja) | 2009-11-24 | 2010-11-24 | Peg化タンパク質の精製方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8697844B2 (enExample) |
| EP (1) | EP2504349B1 (enExample) |
| JP (1) | JP5827955B2 (enExample) |
| CN (2) | CN107383158A (enExample) |
| WO (1) | WO2011064247A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5876208B2 (ja) | 2006-12-15 | 2016-03-02 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 延長されたinvivo半減期を有する第VIIa因子−(ポリ)シアル酸結合体 |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| JP5909755B2 (ja) | 2009-07-27 | 2016-04-27 | リポクセン テクノロジーズ リミテッド | 非血液凝固タンパク質の糖ポリシアル酸化 |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| EP3093029A1 (en) | 2009-07-27 | 2016-11-16 | Baxalta GmbH | Blood coagulation protein conjugates |
| SG178141A1 (en) | 2009-07-27 | 2012-03-29 | Baxter Int | Blood coagulation protein conjugates |
| DK2654794T3 (da) | 2010-12-22 | 2020-06-08 | Baxalta GmbH | Materialer og fremgangsmåder til konjugering af et vandopløseligt fedtsyrederivat til et protein |
| KR102020995B1 (ko) * | 2017-10-30 | 2019-09-16 | 한국코러스 주식회사 | 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법 |
| US12208142B2 (en) * | 2017-12-29 | 2025-01-28 | Hoffmann-La Roche Inc. | Process for providing PEGylated protein composition |
| JP7227633B2 (ja) * | 2017-12-29 | 2023-02-22 | エフ. ホフマン-ラ ロシュ エージー. | Peg化タンパク質組成物を提供するための方法 |
| HRP20220041T1 (hr) | 2017-12-29 | 2022-04-15 | F. Hoffmann - La Roche Ag | Postupak za dobivanje pegiliranog proteinskog pripravka |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714583A (en) | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
| AU6255096A (en) | 1995-06-07 | 1996-12-30 | Mount Sinai School Of Medicine Of The City University Of New York, The | Pegylated modified proteins |
| KR20010043323A (ko) * | 1998-05-06 | 2001-05-25 | 제넨테크, 인크. | 이온 교환 크로마토그래피에 의한 단백질 정제 방법 |
| ATE274522T1 (de) | 1998-06-01 | 2004-09-15 | Genentech Inc | Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie |
| US7265084B2 (en) | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7795210B2 (en) | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
| US7179617B2 (en) | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
| ES2411007T3 (es) | 2001-10-10 | 2013-07-04 | Novo Nordisk A/S | Remodelación y glicoconjugación de péptidos |
| US7473680B2 (en) | 2001-11-28 | 2009-01-06 | Neose Technologies, Inc. | Remodeling and glycoconjugation of peptides |
| US7470779B2 (en) * | 2002-09-20 | 2008-12-30 | Pfizer Inc. | Process for decreasing aggregate levels of pegylated protein |
| WO2006127896A2 (en) | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated factor ix |
| CA2522345A1 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| CA2549413A1 (en) * | 2003-12-03 | 2005-06-23 | Neose Technologies, Inc. | Glycopegylated factor ix |
| US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| CN102719508A (zh) | 2005-08-19 | 2012-10-10 | 诺和诺德公司 | 糖基聚乙二醇化的因子vii和因子viia |
| US20070105755A1 (en) * | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| US8399632B2 (en) | 2007-02-28 | 2013-03-19 | Baxter International Inc. | Method for the purification of recombinant blood coagulation factor IX enriched in sulfated and/or phosphorylated molecules |
| WO2008119815A1 (en) * | 2007-04-02 | 2008-10-09 | Novo Nordisk A/S | Subcutaneous administration of coagulation factor ix |
-
2010
- 2010-11-24 US US13/509,867 patent/US8697844B2/en active Active
- 2010-11-24 EP EP10784769.1A patent/EP2504349B1/en active Active
- 2010-11-24 CN CN201710713355.9A patent/CN107383158A/zh active Pending
- 2010-11-24 CN CN2010800532840A patent/CN102639553A/zh active Pending
- 2010-11-24 JP JP2012540414A patent/JP5827955B2/ja active Active
- 2010-11-24 WO PCT/EP2010/068112 patent/WO2011064247A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013511566A5 (enExample) | ||
| JP2013514073A5 (enExample) | ||
| EA201171199A1 (ru) | Способ очистки рекомбинантного фсг | |
| ES2923018T3 (es) | Métodos de purificación de ARN | |
| BR112013030628A2 (pt) | "métodos para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade (ca), e de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando a coluna de proteína a". | |
| JP2011525523A5 (enExample) | ||
| JP2012018171A5 (enExample) | ||
| PH12020500027A1 (en) | Purification of iduronate-2-sulfatase | |
| JP2011510303A5 (enExample) | ||
| JP2016519137A5 (enExample) | ||
| JP2012518034A5 (enExample) | ||
| GB2443505B (en) | Nucleic acid purification method | |
| JP2013503877A5 (enExample) | ||
| NZ603616A (en) | Apparatus and process of purification of proteins | |
| RU2014111820A (ru) | Способы элиминации вируса | |
| WO2010151632A8 (en) | Protein purification by caprylic acid (octanoic acid ) precipitation | |
| RU2019109975A (ru) | Способы очистки антител | |
| JP2014507368A5 (enExample) | ||
| TW201617360A (zh) | 用於純化蛋白質之方法及試劑 | |
| RU2011125656A (ru) | Очистка полипептидов | |
| JP2014506874A5 (enExample) | ||
| FI3395423T3 (fi) | Vuotaneen affiniteettipuhdistusligandin poistaminen | |
| CN103725664A (zh) | 一种高度纯化激肽释放酶的方法 | |
| JP2014193838A5 (enExample) | ||
| JP2008517046A5 (enExample) |